T-cell vaccine vaccine (Opexa)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameT-cell vaccine vaccine (Opexa)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAcer Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAcer Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A